| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.84B | 4.60B | 4.37B | 4.57B | 2.26B | 1.18B |
| Gross Profit | 4.09B | 3.90B | 3.60B | 3.91B | 1.71B | 1.17B |
| EBITDA | 429.08M | 289.90M | 413.51M | 895.50M | 520.94M | 230.83M |
| Net Income | 217.06M | 190.79M | 290.42M | 676.87M | 494.37M | 122.60M |
Balance Sheet | ||||||
| Total Assets | 4.12B | 3.90B | 4.09B | 4.81B | 3.11B | 2.24B |
| Cash, Cash Equivalents and Short-Term Investments | 258.35M | 2.11B | 1.10B | 1.60B | 842.63M | 515.82M |
| Total Debt | 136.75M | 67.64M | 84.76M | 69.28M | 1.73M | 17.13M |
| Total Liabilities | 1.74B | 1.39B | 1.49B | 2.25B | 1.01B | 575.92M |
| Stockholders Equity | 2.38B | 2.51B | 2.60B | 2.56B | 2.10B | 1.66B |
Cash Flow | ||||||
| Free Cash Flow | -9.27M | 129.04M | -220.15M | 918.45M | 388.68M | 372.34M |
| Operating Cash Flow | 19.36M | 201.00M | -84.09M | 986.85M | 449.85M | 408.29M |
| Investing Cash Flow | 184.48M | 160.10M | -235.03M | -541.55M | -9.72M | -55.01M |
| Financing Cash Flow | -280.44M | -284.96M | -277.80M | -207.72M | -60.74M | -242.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹2.46B | 12.58 | ― | ― | 5.07% | 409.07% | |
61 Neutral | ₹4.57B | 15.80 | ― | 4.65% | 11.08% | 8.22% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% | |
55 Neutral | ₹1.67B | -22.75 | ― | ― | 28.91% | -94.80% | |
52 Neutral | ₹2.55B | -6.96 | ― | ― | 43.91% | -249.30% | |
41 Neutral | ₹13.23B | 43.21 | ― | ― | 6.02% | 2.68% |
Aptech Limited has disclosed that officials from an investigative authority visited its premises on March 18, 2026, in connection with testing-related activities conducted in 2022 under its Institutional Business segment, involving a subsidiary and valued at Rs. 19.9 lakhs. The company stated that the examinations were carried out in line with established processes and audit protocols, that it has fully cooperated with the authorities, and that there is currently no material impact on its operations, financial position or ongoing projects, with business continuing as usual.
Aptech has emphasized the existence of adequate audit trails and data integrity mechanisms for the activities under review and indicated that no specific violations have been cited at this stage. The company has committed to keeping stock exchanges informed of any material developments arising from the investigation, seeking to reassure stakeholders about operational continuity and the limited financial exposure of the matter so far.